Manufacturing roundup: Actylis opens the doors to a facility in Oregon; Emergent reports Q4 numbers

The ingredients manufacturer Actylis has opened a new 30,000-square-foot facility in the city of Eugene, OR.

Actylis CEO Gilles Cottier said in a statement the new site will allow the company to manufacture APIs and intermediates for clinical trials — and on a commercial scale.

“We designed…